OPGN News
Archived Headlines
- Tumor profiling goes public: HTG Molecular Diagnostics sets terms for $50 million IPO 04/28/15
- Week ahead: 6 IPOs planned for the week of Apr 27 04/26/15
- OpGen decreases shares offered, slashes range and adds warrants to upcoming IPO 04/24/15
- Testing for superbugs: OpGen sets terms for $34 million IPO 04/06/15
- Open season for genetic testing: OpGen files for a $35 million IPO 03/03/15
US IPO Weekly Recap: With 8 IPOs it's Bo-Time for Bojangles and no time for biotechs
14 companies were scheduled to go public this week, including 10 health care deals. Only 8 IPOs got through, as 3 biotechs have been pushed back to next week, two companies postponed and one withdrew. however; IPO investors had plenty of options while the NASDAQ...read more
HTG Molecular Diagnostics prices IPO at $14 midpoint and begins trading Wednesday
HTG Molecular Diagnostics, which markets a diagnostic platform for complex molecular profiling, raised $50 million by offering 3.6 million shares at $14, the midpoint of its $13 to $15 range. It priced and began trading on Wednesday. The week's other...read more
OpGen prices IPO at $6, the midpoint of the downwardly revised range
OpGen, which provides genetic tests that identify multi-drug resistant bacterial infections, raised $17 million by offering 2.85 million units at $6, the midpoint of the downwardly revised range of $5.50 to $6.50. Each unit represents one common share and one...read more
Week ahead: 14 IPOs planned for the week of May 4
This could be the busiest 5-day stretch in the IPO market since the week of July 28, 2014, as 14 companies look to raise nearly $2 billion. However, ...read more